Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Roche Diagnostics cobas™ liat Influenza A/B + RSV Multiplex Assay
Automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of Influenza A and B virus and RSV RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.
Supplier: Roche Diagnostics 08160104190
Alert:
Order eligibility is based upon executed contractual agreement.
Description
- No patient age restrictions for test
- Testing accuracy with RT-PCR technology
- Definitive results with no need for interpretation or confirmation
- Fast, easy operation
- Three easy steps
- Results in 20 minutes
![TRUSTED_SUSTAINABILITY](/content/dam/fishersci/glyphs/Sustain_Badge.png)
Specifications
Influenza A: Positive Agreement 98.4%, Negative Agreement 96.5%. Influenza B: Positive Agreement 97.9%, Negative Agreement 99.4%. RSV: Positive Agreement 97.8%, Negative Agreement 98.4% | |
36°F to 46°F | |
87631 | |
Waived | |
Case (Kit) | |
Influenza A: Positive Agreement 98.4%, Negative Agreement 96.5%. Influenza B: Positive Agreement 97.9%, Negative Agreement 99.4%. RSV: Positive Agreement 97.8%, Negative Agreement 98.4% | |
Case (kit) | |
Negative Agreement: Influenza A 96.5%; Influenza B 99.4%; RSV 98.4% |
None | |
Controls purchases separately (FCAT# 23312203) | |
No | |
Influenza A and B, Respiratory Syncytial Virus (RSV) RNA | |
Nasopharyngeal | |
Nucleic Acid RT-PCR Influenza A, Influenza B, RSV | |
20 Tests/Cs. (Kit) | |
20 min. |
Safety and Handling
ShelfLife : 150 Days
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction